Transposable elements, known colloquially as 'jumping genes', constitute approximately 45% of the human genome. Cells utilize epigenetic defenses to limit transposable element jumping, including formation of silencing heterochromatin and generation of piwi-interacting RNAs (piRNAs), small RNAs that facilitate clearance of transposable element transcripts. Here we utilize Drosophila melanogaster and postmortem human brain samples to identify transposable element dysregulation as a key mediator of neuronal death in tauopathies, a group of neurodegenerative disorders that are pathologically characterized by deposits of tau protein in the brain. Mechanistically, we find that heterochromatin decondensation and reduction of piwi and piRNAs drive transposable element dysregulation in tauopathy. We further report a significant increase in transcripts of the endogenous retrovirus class of transposable elements in human Alzheimer's disease and progressive supranuclear palsy, suggesting that transposable element dysregulation is conserved in human tauopathy. Taken together, our data identify heterochromatin decondensation, piwi and piRNA depletion and consequent transposable element dysregulation as a pharmacologically targetable, mechanistic driver of neurodegeneration in tauopathy.
T ransposable elements are categorized as class I, the retrotransposons, or class II, the DNA transposons. Retrotransposons are structurally akin to retroviruses in that they require an RNA intermediate to mobilize. Unlike retroviruses, however, retro transposons lack the ability to move between individuals. DNA transposons, which mobilize via a 'cut and paste' mechanism, are thought to have lost the ability to mobilize in the human genome as a result of imprecise excision and insertion 1 . Organisms ranging from yeast to humans have developed cellular control mechanisms to limit potentially deleterious transposable element activation. Many transposable elements are embedded within highly condensed constitutive heterochromatin and are thus epigenetically silenced 2 . In addition, transposable element transcripts are the targets of a well-conserved pathway involving piRNAs, small regulatory RNAs that bind to transposable element transcripts and mediate their degradation 3 .
The transposon theory of aging posits that transposable elements become deleteriously activated as cellular defense and surveillance mechanisms break down with age 4, 5 . While transposable element activation has also been implicated in cancer 6 and in TDP-43mediated neurodegeneration [7] [8] [9] , the extent to which transposable elements are involved in human disorders and drive disease pathogenesis is unknown. We have previously identified tau-induced decondensation of constitutive heterochromatin as a key event that mediates neuronal death in tauopathy 10 . We hypothesized that taumediated decondensation of constitutive heterochromatin would cause epigenetic de-silencing of transposable elements in the context of Alzheimer's disease and associated tauopathies.
Beginning with a simple model of tauopathy in Drosophila melanogaster 11 , we report significantly altered levels of transposable element transcripts as a consequence of human tau expression in the adult brain. We identify heterochromatin decondensation and depletion of piwi and piRNAs as mechanistic links between pathogenic tau and loss of transposable element control, and demonstrate that pathogenic tau causes active transposable element mobilization in neurons. Dietary restriction and lamivudine (3TC), a nucleoside analog inhibitor of reverse transcriptase that is FDA-approved for the treatment of HIV and hepatitis B, suppress tau-induced transposable element dysregulation and tau-induced neurotoxicity. Using a systematic, unbiased approach, we identify transposable elements that are differentially expressed in postmortem human brain tissue from patients with Alzheimer's disease and progressive supranuclear palsy, a primary tauopathy, and find that the endogenous retrovirus class of transposable elements is increased in the context of human tauopathy. Taken together, our studies identify heterochromatin decondensation and depletion of piwi and piRNAs as key mechanisms driving transposable element dysregulation and subsequent neuronal death in tau-mediated neurodegeneration. In addition, we show that that suppression of transposable element mobilization and resulting neurodegeneration can be achieved by environmental and pharmacological intervention.
Results
Drosophila models of human tauopathy have altered levels of transposable element transcripts. D. melanogaster provides a genetically tractable platform that can be used to identify cellular mechanisms implicated in disease states and to determine whether they are causal for the disease process. To investigate a potential role for transposable element dysregulation as a consequence of pathogenic tau, we began with a Drosophila model of tauopathy 11 Articles NATuRe NeuRosCieNCe involving neuron-specific expression of tau R406W , a mutant form of human tau that is associated with autosomal dominant tauopathy 12 . Drosophila models of human tauopathy have progressive, ageassociated neuronal death, a shortened lifespan, and decreased locomotor activity 10, 11 . In addition, neuronal phenotypes of tau transgenic Drosophila mimic features of human Alzheimer's disease and associated tauopathies, including but not limited to aberrant tau phosphorylation 13 , oxidative stress 14 , DNA damage 15, 16 , Tau  Control   1731{}2219  412{}1431  412{}2  412{}5  412{}882  412{}CG33267iso-1  copia{}1016  copia{}1349  copia{}1391  copia{}1467  copia{}298  copia{}342  copia{}387  copia{}539  copia{}631  copia{}837  copia{}920  copia{}988  Doc{}1000  Doc{}970  F{}1370  flea{}810 HeT-A{}4795 HeT-A{}4800 HeT-A{}5504 HeT-A{}6255 HeT-A{}6256 HeT-A{}6270 HeT-A{}6276 invader2{}2574 invader4{}1669 invader4{}2284 mdg1{}CG42335iso- R406W transgenic Drosophila heads versus control by RNA-seq (two-sided Wald test, FDR, P < 0.01, n = 3 biologically independent replicates, each consisting of RNA pooled from 6 heads). b, Pie charts depicting all classes of transposable elements in Drosophila, and classes of transposable elements that are increased or decreased in tau R406W transgenic Drosophila. c,d, NanoString-based validation of transposable element transcripts that are increased in tauopathy by RNA-seq (c) and transposable elements transcripts that are decreased in tau R406W transgenic Drosophila by RNA-seq (d); n = 6 biologically independent replicates, each consisting of RNA pooled from 6 heads; values are relative to control, which was set to 1. Unpaired, two-tailed Student's t-test, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Values are mean ± s.e.m. All flies are 10 d old. Full genotypes are listed in Supplementary Table 1 . Transposable elements recognized by generic probes are listed in Supplementary Table 4 .
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We performed 100-bp, paired-end sequencing of RNA isolated from control and tau R406W transgenic Drosophila heads at day 10 of adulthood, an age at which neuronal death and locomotor deficits are detectable in tau R406W transgenic flies but before the age at which survival is at exponential decline 16 . We identified 50 transposable elements that were significantly increased at the transcript level in tau transgenic Drosophila compared to controls and 60 transposable elements that were significantly decreased ( Fig. 1a , Supplementary Fig. 1 and Supplementary Tables 1 and 2 ). For several subgroups of transposable elements, we found that multiple members of the same subgroup, such as copia, HeT-A and Quasimodo, were increased in tau R406W transgenic Drosophila while members of other subgroups, such as Burdock and Blood, were decreased in tau R406W transgenic Drosophila. These data suggest that aberrant expression of transposable elements in tauopathy is a regulated, rather than stochastic, process. The most abundant class of differentially expressed elements in tauopathy were class I long terminal repeat (LTR) retrotransposons, even though the majority of transposable elements in Drosophila are classified as class II DNA transposons (Fig. 1b) .
The complexity and repetitive nature of transposable elements present challenges to RNA sequencing (RNA-seq) analysis, which is associated with a greater frequency of false positives and negatives compared to analysis of canonical messenger RNAs. As secondary validation of our RNA-seq analyses, we prepared a custom NanoString codeset consisting of a panel of probes recognizing transposable elements that were identified as differentially expressed in tau transgenic Drosophila by RNAseq ( Supplementary Table 3 ). NanoString technology combines transcript-specific color-coded barcodes with fluorescence imaging to sensitively quantify transcript levels 19 . When possible, we created 'generic' NanoString probes to recognize the differentially expressed transposable elements within a transposable element subgroup ( Supplementary Table 4 ). While a calculation of the fold-change estimate for each element generated by RNA-seq versus the fold-change for NanoString ( Supplementary Fig. 1b ) suggests a moderate to strong relationship between RNA-seq and NanoString, not all transposable elements that were called as differentially expressed in tau transgenic Drosophila by RNA-seq reached statistical significance by NanoString analysis. Fourteen of 25 probes were confirmed by NanoString as significantly increased in heads of tau R406W transgenic Drosophila (Fig. 1c ), while 6 of 22 probes were confirmed as significantly decreased (Fig. 1d ). These analyses also revealed that the transposable elements transcripts that increased in response to pathogenic tau generally had a greater magnitude of change than transposable element transcripts that decreased in response to pathogenic tau.
We hypothesized that aberrant transposable element expression would be relevant to the larger group of tauopathies, including Alzheimer's disease, that are pathologically defined by deposition of wild-type tau in the brain. To test this hypothesis, we assayed transposable element transcript levels by NanoString in Drosophila expressing human wild-type tau (tau WT ; Supplementary Fig. 2a ), which induces neuronal death in Drosophila 11 , albeit to a lesser extent than tau R406W . Multiple previous studies report that expression of human wild-type and R406W mutant tau involves the same main mechanisms of tau-induced neurotoxicity in Drosophila models 10, 16, 20 . Pan-neuronal expression of tau WT significantly increased 10 of 25 and decreased 8 of 22 probes recognizing transposable elements that were identified as increased or decreased, respectively, in tau R406W Drosophila by RNA-seq ( Supplementary  Fig. 2b,c ), suggesting that aberrant transposable element expression is relevant to the greater family of sporadic tauopathies that involve only wild-type tau. Supplementary Table 1 .
Loss of transposable element silencing mediates tau-induced neurotoxicity in
transposable element transcripts in the brain. Transposable element activation is classically considered a deleterious event, as mobilization can cause genomic instability 21 . It is now understood, however, that transposable element RNAs have regulatory roles within the cell 1 . In addition, active transposable element mobilization during neurogenesis is thought to positively contribute to somatic diversification 22 . To establish whether dysregulation of transposable element expression in the adult brain is beneficial, detrimental or neutral in the context of tauopathy, we tested whether genetic manipulation of flamenco, a locus in Drosophila that is known to restrict transposable element mobilization, would modify tau R406W -induced neurotoxicity. Homozygous 'permissive' loss-of-function alleles of flamenco allow transposable element mobilization and increase transposable element copy number within the Drosophila genome 23, 24 . Two different heterozygous loss-of-function alleles of flamenco 23,24 did not induce neuronal death or locomotor deficits in controls, but significantly enhanced neuronal death in tau R406W transgenic Drosophila ( Fig. 2a ) and exacerbated tau-induced locomotor deficits ( Fig. 2b) . Importantly, flamenco mutations did not affect total protein levels of transgenic tau ( Supplementary Fig. 3a ). Ectopic expression of proteins associated with aberrant activation of the cell cycle in postmitotic neurons is a well-described feature of human tauopathy 25 . Studies in Drosophila indicate that cell cycle activation causes neuronal death in tauopathy and that activation of the cell cycle in neurons is sufficient to induce neuronal death 18 . We found that heterozygous loss of flamenco function exacerbated tau-induced activation of the cell cycle in neurons as assessed by staining with an antibody recognizing proliferating cell nuclear antigen (PCNA) ( Fig. 2c ). Taken together, these data suggest that loss of transposable element silencing in tau transgenic Drosophila is causally linked to neuronal death and promotes neuronal death through aberrant activation of the cell cycle in postmitotic neurons.
The flamenco locus harbors piRNAs that specifically degrade gypsy, Idefix and ZAM transposable element transcripts 24 , among others. To determine whether flamenco mutation affects the specific panel of transposable elements that are aberrantly expressed in tau R406W transgenic Drosophila, we performed NanoString analyses on flamenco loss-of-function mutants ( Supplementary Fig. 3 ). Rather than a general effect on the panel of transposable elements that are dysregulated by pathogenic tau, these analyses suggested that enhancement of tau-induced neurotoxicity by flamenco loss of function was due to activation of specific elements affected by pathogenic tau and/or additional elements outside of our NanoString codeset.
Piwi and piRNA depletion is a mechanistic driver of transposable element transcription in tauopathy. Since flamenco is known to encode a major piRNA cluster 3, 26 and piRNAs have recently been reported to be differentially expressed in the brain in human Alzheimer's disease 27, 28 , we next determined whether piR-NAs are involved in dysfunctional transposable element control in the tauopathy-affected Drosophila brain. Small RNA sequencing revealed a significant decrease in 46 of 50 differentially expressed piRNAs in heads of tau transgenic Drosophila at day 10 of adulthood ( Fig. 3a and Supplementary Tables 5 and 6 ). In addition, protein levels of piwi, a central regulator of piRNA biogenesis, were depleted in brains of tau transgenic Drosophila as assessed by both immunofluorescence ( Fig. 3b ) and western blotting ( Fig. 3c ).
While the function of piwi in regard to piRNA production and transposable element silencing is well established in the germline 29 , and piRNAs are known to exist in the Drosophila and mammalian brain 30, 31 , it is unknown whether piwi reduction affects transposable element transcripts in the brain. To directly quantify the effects of piwi reduction on the panel of transposable elements that were differentially expressed in tau R406W transgenic Drosophila, we used our custom NanoString codeset to assay transposable element transcript levels in response to pan-neuronal RNA interference (RNAi)mediated piwi knockdown in the absence of transgenic tau. These data indicated that pan-neuronal piwi knockdown ( Supplementary  Fig. 4a ) was sufficient to elevate transcript levels of most of the transposable elements that are increased in tau R406W transgenic Drosophila (Fig. 3d ), suggesting that tau-induced reduction of piwi and piRNAs is a major contributor to the transposable element expression profile in brains of tau transgenic Drosophila.
We next determined whether piwi depletion is a causal mediator of neuronal death in tauopathy. RNAi-mediated piwi knockdown using two different, non-overlapping RNAi lines was semi-lethal in the context of transgenic tau expression. In the absence of tau, piwi knockdown was sufficient to induce neuronal death by day 10 of adulthood ( Fig. 3e ). Per PCNA staining, pan-neuronal piwi reduction was also sufficient to activate the cell cycle in neurons ( Supplementary Fig. 4b ), suggesting that pathogenic tau acts through piwi reduction to mediate aberrant cell cycle activation and consequent neuronal death.
We next determined whether pan-neuronal overexpression of piwi 32 would reduce aberrant transposable element expression and neuronal death in brains of tau transgenic Drosophila. Compared to tau expressed alone, piwi overexpression significantly reduced transposable element transcripts that are elevated in tau transgenic Drosophila (Fig. 3f ). In further support of piwi reduction as a causal contributor to tau-induced neurotoxicity, pan-neuronal piwi overexpression significantly reduced neuronal death in tau transgenic Drosophila (Fig. 3g ) without affecting total levels of transgenic tau protein ( Supplementary Fig. 4c ). These data suggest that tau-induced piwi reduction depletes piRNAs, which significantly increases transposable element transcripts and causally contributes to tau-induced neurotoxicity.
Fig. 3 | Decreased expression of piwi and piRNAs mediate pathogenic tau R406W -induced increase in transposable element transcripts and drive neuronal
death. a, Heat map reflecting fold change of piRNAs that are differentially expressed in tau R406W transgenic Drosophila heads versus controls as assessed by small RNA-seq (two-sided Wald test, FDR, P < 0.01, n = 4 biologically independent replicates, each consisting of RNA pooled from 6 heads). b,c, Decreased levels of piwi protein (red) in cortex of the tau R406W transgenic Drosophila brain as assessed by immunostaining (b) and western blotting (c) (unpaired, two-tailed Student's t-test, **P = 0.005, n = 6 animals per genotype). In b, piwi immunostaining was repeated in 6 animals of each genotype with similar results. Western blot is cropped in c; full blot presented in Supplementary Fig. 10 . d, NanoString analysis of transposable element expression in response to RNAi-mediated knockdown of piwi versus control (unpaired, two-tailed Student's t-test, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001; n = 6 biologically independent replicates, each consisting of RNA pooled from 6 heads; values are relative to control, which was set to 1). e, Neuronal death assayed by TUNEL in Drosophila caused by pan-neuronal RNAi-mediated knockdown of piwi (one-way ANOVA with Tukey's multiple comparison test, ****P < 0.0001, n = 20 animals per genotype). f, NanoString analysis of transposable element expression in response to pan-neuronal piwi overexpression in tau R406W transgenic Drosophila versus tau expressed alone (unpaired, two-tailed Student's t-test, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001; n = 6 biologically independent replicates, each consisting of RNA pooled from 6 heads; values are relative to tau expressed alone, which was set to 1). g, Neuronal death assayed by TUNEL in tau R406W transgenic Drosophila with pan-neuronal piwi overexpression (one-way ANOVA with Tukey's multiple comparison test, ****P < 0.0001, n = 20 animals per genotype). All flies were 10 d old. Values are mean ± s.e.m. Full genotypes are listed in Supplementary  Table 1 . Transposable elements recognized by generic probes are listed in Supplementary Table 4 .
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Decondensation of heterochromatin contributes to aberrant transposable element transcription in the adult Drosophila brain. We have previously reported widespread relaxation of constitutive heterochromatin, a form of hypercondensed DNA, in postmortem brains from patients with Alzheimer's disease, which is the most common tauopathy, and in Drosophila and mouse models of tauopathy 10 . Tau-induced heterochromatin relaxation mediates neurodegeneration, as loss-of-function mutations in Su(var)205 33 and Su(var)3-9 34 , genes, encoding heterochromatin protein 1 (HP1) and a histone 3 Lys9 methyltransferase, respectively, further deplete constitutive heterochromatin in tau transgenic Drosophila and enhance tau-induced neuronal death 10 .
On the basis of previous studies that identified constitutive heterochromatin as a silencing mechanism for transposable elements 35 , we next determined whether genetically promoting heterochromatin relaxation would affect the transposable elements that are differentially expressed in tau transgenic Drosophila. NanoString analyses showed that genetically promoting heterochromatin relax- caused an increase in most of the transposable element transcripts that were identified as significantly increased in tau transgenic Drosophila by RNA-seq ( Supplementary Fig. 5a,b ). In the context of our previous report identifying tau-induced heterochromatin decondensation as a central mediator of neurotoxicity in tauopathy, these data suggest that tau-induced heterochromatin decondensation contributes to transposable element dysregulation in brains of tau transgenic Drosophila.
Active transposable element mobilization in neurons of tau transgenic Drosophila. Fifty-six percent of the transposable element transcripts that were significantly increased in tau transgenic Drosophila were full-length class I retrotransposons that are fully capable of mobilization. As transcription of DNA to RNA is the first step in retrotransposon mobilization, we next determined whether transposable elements actively mobilize in the context of tauopathy.
Specifically, we used the gypsy-TRAP reporter, a GFP-based reporter of copia and/or gypsy insertion into the ovo locus that was developed to detect transposable element mobilization 4 . Because the gypsy-TRAP reporter utilizes the GAL4-UAS system that we normally use to express transgenic tau pan-neuronally, we instead used an existing tauopathy model that relies on direct fusion of the human tau transgene to GMR, a retinal neuron driver. These flies harbor the V337M disease-associated 12 form of human mutant tau. Neuronal death in Drosophila models of tauopathy is age-dependent. Accordingly, we did not detect transposable element mobilization in tau V337M transgenic Drosophila by either gypsy-TRAP GFP reporter fluorescence or immunoblotting at day 1 of adulthood, but detected a significant increase of transposable element mobilization in tau transgenic Drosophila by both GFP fluorescence and immunoblotting at day 10 of adulthood. The significant increase in transposable element mobilization in tauopathy compared to controls was sustained in 40-d-old adults (Fig. 4a,b ). V337M transgenic Drosophila compared to control. Brains were stained with the cTau antibody (red) to recognize transgenic tau (unpaired, two-tailed Student's t-test, n = 6 animals per genotype per age; n.s., not significant; **P = 0.004, ***P = 0.0001). b, Quantification of gypsy-TRAP activation by western blotting with an antibody recognizing GFP (unpaired, two-tailed Student's t-test; n.s., not significant; **P = 0.003, ****P < 0.0001). Western blot is cropped; full blot presented in Supplementary Fig. 10 . n = 6 animals per genotype per age. Values are mean ± s.e.m. Full genotypes are listed in Supplementary Table 1 .
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Dietary restriction and inhibition of reverse transcriptase protect against tau-induced transposable element dysregulation and suppress neurotoxicity in tau transgenic Drosophila. Dietary restriction extends lifespan in invertebrate and vertebrate systems 36 and reduces age-related transposable element mobilization events in the Drosophila fat body 5 . Using the gypsy-TRAP GFP-based reporter of transposable element mobilization 4 , we found that 66% dietary restriction reduced tau-induced transposable element mobilization in adult Drosophila neurons (Fig. 5a,b) . As assessed by NanoString, dietary restriction significantly reduced the copia family at the transcript level, as well as several other transposable elements that were significantly increased in tau transgenic Drosophila (Supplementary Fig. 6 ). TUNEL revealed that dietary restriction suppressed tau-induced neuronal death (Fig. 5c ).
Having established that tau-induced transposable element dysregulation is amenable to suppression, we took a pharmacological approach to reduce transposable element mobilization in tauopathy. Like retroviruses, retrotransposons encode machinery, including a capsid protein, polymerase, integrase and reverse transcriptase, needed to copy themselves and insert the new copy into Supplementary Table 1 .
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NATuRe NeuRosCieNCe the genome 37 . 3TC is a water-soluble nucleoside analog inhibitor of reverse transcriptase 38 that is FDA-approved for treatment of HIV and AIDS and of hepatitis B, both of which are caused by retroviruses. Like dietary restriction, 3TC is reported to reduce age-associated transposable element mobilization in the Drosophila fat body 5 . Tau transgenic flies treated with 10 mM 3TC had significantly reduced gypsy-TRAP reporter activation in the brain (Fig. 6a,b ).
In addition, 3TC treatment significantly reduced tau-induced neuronal death ( Fig. 6c ) and significantly alleviated tau-induced locomotor deficits (Fig. 6d ) in a dose-dependent manner ( Supplementary Fig. 7a,b) . Taken together, these data provide further evidence that transposable element dysregulation causes the disease process in tauopathy and is responsive to environmental and pharmacological inhibition. Supplementary Fig. 10 . c, 3TC (10 mM) significantly reduces tau R406W -induced neuronal death assessed by TUNEL (one-way ANOVA with Tukey's multiple comparison test, ****P < 0.0001, n = 20 animals per genotype, per treatment). d, 3TC (10 mM) significantly alleviates tau R406W -induced deficits in locomotor activity (one-way ANOVA with Tukey's multiple comparison test, ***P = 0.0008, ****P < 0.0001, n = 20 animals per genotype per treatment). All flies were 10 d old. Values are mean ± s.e.m. Full genotypes are listed in Supplementary Table 1 .
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Aberrant transposable element transcription in human tauopathy. We next analyzed transposable element expression in human tauopathy using RNA-seq data from cortex (Fig. 7a,b ) and cerebellum ( Supplementary Fig. 8a,b ) of postmortem human controls and subjects with Alzheimer's disease and progressive supranuclear palsy (Supplementary Table 7 ). As in tau transgenic Drosophila, we found that specific subgroups of transposable elements were upregulated in human tauopathy while other subgroups were downregulated. Alzheimer's disease
Increased in AD 
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Among transposable elements that were upregulated in cortex and cerebellum of both tauopathies, we found a significant over-representation of endogenous retroviruses, while non-LTR retrotransposons were significantly over-represented among transposable elements that were downregulated in cortex and cerebellum of both tauopathies ( Fig. 7c and Supplementary Fig. 8c ). We hypothesized that transposable element expression profiles of Alzheimer's disease and progressive supranuclear palsy would more closely resemble each other than controls. Principal component analysis supported this hypothesis; in particular, control samples had significantly lower values in the second principal component compared to Alzheimer's disease and progressive supranuclear palsy samples in both cortex (Fig. 7d ) and cerebellum ( Supplementary  Fig. 8d ). We computed the median of the first two principal components over all tauopathy samples and found that the distance of control samples to the median center was significantly further than in tauopathy samples in both cortex (Fig. 7e ) and cerebellum ( Supplementary Fig. 8e ). Taken together, analyses of human transposable elements revealed a significant transcriptional increase in endogenous retroviruses and a significant decrease in non-LTR retroelements in postmortem human brain in both Alzheimer's disease and progressive supranuclear palsy. In addition, these data suggest that transposable element dysregulation in human tauopathy is a regulated rather than stochastic process, consistent with our studies in tau transgenic Drosophila.
Discussion
We have uncovered a therapeutically targetable mechanism whereby pathogenic tau drives neuronal death ( Supplementary  Fig. 9 ). Specifically, our studies identified dysregulation of transposable elements as a consequence of pathogenic tau and a driver of aberrant cell cycle activation in neurons and subsequent neuronal death. We identified genetic, dietary and pharmacological approaches to reduce transposable element dysregulation and suppress tau-induced neurotoxicity in Drosophila. We applied an unbiased transcriptomic approach to extend our findings to postmortem human brains and identified differentially expressed transposable elements in Alzheimer's disease and progressive supranuclear palsy.
Because the complexity and repetitive nature of transposable elements present challenges to RNA-seq analysis, which is associated with a greater frequency of false positives and negatives compared to analysis of canonical messenger RNAs, we performed secondary validation of differentially expressed transposable element transcripts in tau transgenic Drosophila by NanoString. While NanoString data showed a similar expression trend for most of the transposable elements that were identified as differentially expressed in tau transgenic Drosophila by RNA-seq, some of the elements were not confirmed as differentially expressed by NanoString. These data reveal the limitations of each assay when analyzing transposable element transcripts and stress the importance of rigorous secondary validation. Since many members of the copia family are increased at the transcript level in both RNA-seq and NanoString analyses, we speculate that gypsy-TRAP reporter activation is a result of copia insertion into the ovo locus, rather than gypsy. Our attempts to sequence de novo copia insertions within the ovo locus in homogenates prepared from tau transgenic Drosophila heads resulted in a high frequency of mismatches (data not shown), which is likely a result of the stochastic nature of transposable element insertion.
According to current understanding, cells have two layers of defense against potentially deleterious transposable element activation: transposable element transcription is limited by heterochromatin-mediated silencing, and transposable element transcripts are cleared from the cell by piRNA-mediated degradation. We found that both mechanisms of transposable element suppression were compromised in tauopathy. We speculate that tau-induced heterochromatin decondensation facilitates active transcription of transposable elements and that tau-induced piwi and piRNA reduction allows those transcripts to persist. While our results are consistent with the effects of heterochromatin decondensation and piwi reduction on transposable element expression that have been reported in the Drosophila germline 3, 39 , our studies reveal a previously undocumented role for heterochromatin-and piRNA-mediated transposable element silencing in the brain. On the basis of studies in the germline reporting a direct interaction between piwi and HP1 40 and a requirement for Rhino, a member of the HP1 subfamily, for piRNA production 41 , it is possible that a direct interaction between piwi and HP1 is also required to silence transposable elements in the brain.
Among upregulated transposable elements in human tauopathy, the human endogenous retrovirus (HERV) family, including HERV-K, was significantly over-represented. Elevated HERV-K transcripts are associated with amyotrophic lateral sclerosis (ALS) 8 and many human cancers, including melanoma, breast cancer, germ cell tumors, renal cancer and ovarian cancer 42 . A causal association between HERV-K and neuronal dysfunction has previously been established, as ectopic expression of HERV-K or the retroviral envelope protein that it encodes decreases synaptic activity and induces progressive motor dysfunction in mice 8 . Antiretroviral reverse transcriptase inhibitors inhibit HERV-K activation in cultured cells 43 and are now in clinical trials for the treatment of ALS. On the basis of the data presented here, reverse transcriptase inhibitors have significant potential as a therapeutic strategy for the treatment of neurodegenerative tauopathies, including Alzheimer's disease.
The ability of flamenco loss-of-function mutations to enhance tau-induced neurotoxicity and the ability of piwi overexpression, dietary restriction and inhibition of reverse transcriptase to reduce transposable element dysregulation and suppress tau-induced neurotoxicity suggest that tau-induced transposable element dysregulation is deleterious to neuronal survival. In addition to the detrimental effects of transposable element jumping, doublestranded RNAs produced by transposable element transcripts, including HERVs, can trigger a type I interferon response through the innate immune system 44 . In light of the HERV increase in human tauopathy and the involvement of the innate immune response as a disease-promoting mechanism in Alzheimer's disease 45 , it is tempting to speculate that expression of endogenous retroviruses in human tauopathy contributes to neuroinflammation, in addition to promoting genomic instability. In future studies, it will be important to investigate a potential effect of transposable element activation on the innate immune response in the context of tauopathy.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41593-018-0194-1.
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Methods Drosophila genetics. Drosophila crosses and aging were performed at 25 °C with a 12 h light/dark cycle at 60% relative humidity on a standard diet (Bloomington formulation). Full genotypes are listed in Supplementary Table 1 . Pan-neuronal expression of transgenes, including RNAi-mediated knockdown, in Drosophila was achieved using the GAL4/UAS system 46 with the elav promoter driving GAL4 expression. Retinal expression of transgenes in gypsy-TRAP studies was achieved using the retinal glass multiple reporter (GMR) promoter. elav-GAL4/ + , GMR-Tau V337M , UAS-GFP, flam KG00476 , flam OR , Su(var)205 5 and Su(var)3-9 2 were obtained from the Bloomington Stock Center. piwi v101658 and piwi v22235 were obtained from the Vienna Drosophila Resource Center 47 (VDRC, http://www.vdrc.at). UAS-tau R406W and UAS-tau WT were a gift from Mel Feany. Gypsy-TRAP was a gift from Josh Dubnau. UAS-HA-piwi was a gift from Ruth Lehmann. An equal number of males and females were used in all Drosophila assays with the exception of gypsy-TRAP and flamenco genetic manipulations. Experiments using the gypsy-TRAP reporter or flamenco require two genetic elements on the X chromosome, and thus all data points are from female flies.
RNA sequencing and data analyses. Library preparation and sequencing were performed by the Genome Sequencing Facility at Greehey Children's Cancer Research Institute at the University of Texas Health San Antonio. For standard RNA-seq, three independent biologically independent replicates were sequenced, each consisting of 500 ng of total RNA from 6 pooled Drosophila heads (18 heads total). Extracted RNA was used for library preparation according to the KAPA Stranded RNA-seq Kit with RiboErase (HMR) sample preparation guide. After quantification by Qubit and Bioanalysis, libraries were pooled for cBot amplification and sequenced on the Illumina HiSeq 3000 platform with 100-base-pair paired-end sequencing.
For small RNA-seq, four independent biological replicates were sequenced. 500 ng of total RNA from pooled Drosophila heads was used for library preparation according to the NEBNext small RNA sample preparation guide. Due to the abundance of the 2 S rRNA in Drosophila, we included an additional 2 S blocking step using the oligonucleotide 5′ -TAC AAC CCT CAA CCA TAT GTA GTC CAA GCA/3SpC3/-3′ as described 48 . 2 S rRNA blocking was performed directly after 3′ SR adaptor ligation. 1 μ M of the 2 S rRNA blocking oligonucleotide was added directly to each ligation reaction on ice, and reactions were incubated at 90 °C for 30 s, then 65 °C for 5 min. After 5 min, we added 1 μ l of SR RT primer and proceeded as described in the NEBNext protocol. After small RNA-seq libraries were quantified by Qubit and Bioanalysis, samples were pooled for cBot amplification and sequenced on the Illumina HiSeq 3000 platform with 50-basepair single-read sequencing. After standard and small-RNA sequencing, CASAVA was used for demultiplexing and fastq files were generated for each sample.
For data cleaning, SortMeRNA 49 v2.1 was used to identify and exclude ribosomal RNA reads, and Trimmomatic 50 v0.36 was used to remove Illumina adaptors. FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) v0.11.5 was used for a quality check before and after the above cleaning steps. The quality of bases in the cleaned reads was above 28 (Sanger/Illumina 1.9 encoding). Reads were aligned to the transposon reference FASTA files (FlyBase 51 release 6.12), and the quantity of each transposable element was calculated using Salmon 52 v0.7.2. On average, 9 million reads were mapped per sample. DESeq2 53 v1.14.1 was used to identify sequences that were differentially expressed in tau transgenic Drosophila compared to controls. Ensembl BioMarts 54 was used to assign genomic locations of differentially expressed transcripts (Supplementary Table 2 ). Pheatmap (https://CRAN.R-project.org/package= pheatmap) v1.0.8 and Pigengene 55 v1.3.4 R 56 packages were used to generate heat maps. Values in transposable element heat maps are standardized transcripts per million 57 (TPM). For presentation clarity in Fig. 1 , we subtracted the TPM value of each transposable element from its average across all samples and then divided the difference by the s.d. of the TPM value of that particular transposable element. Unscaled heat maps ( Supplementary Fig. 1 ) represent raw TPM.
piRNA small RNA-seq analyses were similar to the above, with some exceptions. As some tRNAs are misannotated as piRNAs, piRNAs that were a subsequence of a tRNA (FlyBase 51 release 6.16) were removed from analysis. Reads were mapped to the remaining piRNA sequences (piRNABank 58 ) as the reference. On average, 16 million reads were mapped per sample. piRNAs with low coverage were excluded as follows. If the sum of reads that mapped to a piRNA in all four tau transgenic Drosophila samples was less than 3, we considered its expression undetectable in tau transgenic samples. Similarly, if the sum of reads that mapped to a piRNA in all four control normal samples was less than 3, we considered its expression undetectable in controls. If a piRNA had undetectable expression values both tau transgenic and control samples, it was excluded from our analysis. Raw data for small RNA-seq are included in Supplementary Table 5 , and genomic locations of differentially expressed piRNAs are included in Supplementary Table 6 .
NanoString. We worked with bioinformaticians at NanoString Technologies, Inc. to create a custom codeset consisting of 50 probes: 47 transposable elements identified as differentially expressed by RNA-seq, plus three internal control genes (RpL32, CG15117, cyp33) . Codeset sequences are included in Supplementary  Table 3 . 100 ng of total RNA from pooled Drosophila heads was used for NanoString nCounter XT Codeset Gene Expression Assays according to the manufacturer's protocol. Samples were analyzed by the nCounter Prep Station, and results were analyzed using the nCounter Digital Analyzer.
Immunofluorescence and histology. For tau, piwi and GFP immunofluorescence, Drosophila brains were dissected in PBS and fixed in methanol for 20 min. After blocking with 2% milk in 0.3% Triton in PBS for 30 min, brains were incubated with primary antibody diluted in blocking solution overnight at 4 °C. After washing with 0.3% Triton in PBS, brains were incubated with Alexa488-or Alexa555-conjugated secondary antibodies for 2 h at room temperature. Slides were washed again and incubated with DAPI for 2 min to stain nuclei. Brains were visualized by confocal microscopy (Zeiss LSM 780 NLO with Examiner), and ImageJ was used for analysis. All images shown are a single slice. TUNEL staining was performed in 4-µ m sections from formalin-fixed, paraffin-embedded Drosophila heads. Secondary detection was performed with DAB. TUNEL-positive neurons were counted throughout the entire brain by bright field microscopy. Antibody concentrations and sources are listed in Supplementary Table 8 .
Western blotting. Frozen Drosophila heads were homogenized in 20 µ l Laemmli sample buffer, boiled for 10 min, and analyzed by 4-20% SDS-PAGE. After transfer to nitrocellulose membranes, antigen retrieval was performed by microwaving membranes in 1 L of PBS for 15 min. Equal loading was assessed by Ponceau S staining. After blocking membranes in PBS plus 0.05% Tween and 2% milk, membranes were incubated with primary antibodies overnight at 4 °C. After washing, membranes were incubated with HRP-conjugated secondary antibodies for 2 h at room temperature. Blots were developed with an enhanced chemiluminescent substrate. Antibody concentrations and sources are listed in Supplementary Table 8 . Full scans of western blots are provided in Supplementary Fig. 10 .
Locomotor activity. Walking activity was assayed as described previously 10 .
Dietary restriction and 3TC treatment. 'Standard' diet consists of 1.5% yeast, 6.6% light corn syrup, 0.9% soy flour, 6.7% yellow cornmeal, 0.5% agar. 'Dietary restriction' diet consists of 0.5% yeast, 2.2% light corn syrup, 0.9% soy flour, 6.7% yellow cornmeal, 0.5% agar (all wt/vol). Flies were collected at day 1 of adulthood and placed on a standard or restricted diet. Flies were transferred to fresh food every other day until they were 10 d old, at which point they were fixed, frozen or assessed for locomotor activity.
For drug treatment, flies were collected at 2 d old and transferred to standard food or food containing 3TC (Fisher, no. 50731692, 10 mM except in Supplementary Fig. 3 ), which was dissolved in water. Flies were transferred to fresh food every other day until they were 10 d old, at which point they were fixed, frozen or assessed for locomotor activity.
Analysis of human RNA-seq data. The Mayo RNA-seq Study on
Neuropathological Diseases generated whole-transcriptome data for cerebellum and temporal cortex samples from 312 North American subjects of European ancestry. These subjects were diagnosed with Alzheimer's disease, progressive supranuclear palsy or pathologic aging, or were elderly controls without neurodegenerative disorders 59 . We downloaded the corresponding clinical data (covariates) from the Accelerating Medicines Partnership -Alzheimer's Disease (AMP-AD) Knowledge Portal 60 . Specifically, we used the synapseClient R package v1.15-0 (http://docs.synapse.org/articles/getting_started.html) to download temporal cortex (syn5223705) and cerebellum (syn3817650) clinical data. Twelve cortex (syn6126114) and 10 cerebellum (syn6126119) samples were excluded due to low quality 61, 62 . In this study, we also excluded 9 cortex and 15 cerebellum samples that had an RNA integrity number (RIN) 63 less than 7. After this filtering, 80 Alzheimer's disease, 82 progressive supranuclear palsy and 21 control cortex samples were available, along with 76 Alzheimer's disease, 78 progressive supranuclear palsy and 25 control cerebellum samples. Nilufer Taner at the Mayo Clinic provided us with unprocessed RNA-seq data. We converted raw bam files to fastq files using the Picard SamToFastq v2.10.10 tool (http:// broadinstitute.github.io/picard). We downloaded human transposable elements from the Genetic Information Research Institute (GIRI) RepBase 64 database in fasta format (http://www.girinst.org/repbase/update/browse.php?type= All&format= FASTA&autonomous= on&nonautonomous= on&simple= on&division= Homo+ sapiens&letter= A). The file contains 1,073 unique sequences, including the 549 ancestral repeats that are shared among all mammals. Using the same pipeline that we described for the analysis of Drosophila RNA-seq data, we cleaned the fastq files, aligned them to the human transposable element sequences, and performed differential expression analysis.
Principal component analyses (PCA) of human RNA-seq data. We used DESeq2 package and a likelihood ratio test to identify 19 transposable elements that have variable expression in any of the three Alzheimer's disease, progressive supranuclear palsy or control conditions in cortex (Supplementary Table 7 ). We then oversampled the control samples to balance the number of samples in each condition by repeating each control sample four times. We performed PCA 1 nature research | reporting summary A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Our web collection on statistics for biologists may be useful.
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Data collection
Drosophila: For standard RNA-seq, three independent biologically independent replicates were sequenced, each consisting of 500 ng of total RNA from six pooled Drosophila heads (18 heads total). Extracted RNA was used for library preparation according to the KAPA Stranded RNA-seq Kit with RiboErase (HMR) sample preparation guide. After quantification by Qubit and Bioanalysis, libraries were pooled for cBot amplification and sequenced on the Illumina HiSeq 3000 platform with 100 base pair paired-end sequencing. For small RNA-seq, four independent biological replicates were sequenced. 500 ng of total RNA from pooled Drosophila heads was used for library preparation according to the NEBNext small RNA sample preparation guide. Due to the abundance of the 2S rRNA in Drosophila, we included an additional 2S block step using the oligo (5'-TAC AAC CCT CAA CCA TAT GTA GTC CAA GCA/3SpC3/-3') as described48. 2S rRNA blocking was performed directly after 3' SR adapter ligation. 1 μM of the 2S rRNA block oligo was added directly to each ligation reaction on ice, and reactions were incubated at 90°C for 30 sec, then 65°C for 5 min. After 5 min, 1 μl of SR RT primer was added and we proceeded as described in the NEBNext protocol. After small RNA-seq libraries were subjected to quantification by Qubit and Bioanalysis, samples were pooled for cBot amplification and sequenced on the Illumina HiSeq 3000 platform with 50 base pair singleread sequencing.
Human: The Mayo RNA-seq Study on Neuropathological Diseases generated whole transcriptome data for cerebellum and temporal cortex samples from 312 North American Caucasian subjects. These subjects were diagnosed with Alzheimer's disease, progressive supranuclear palsy, pathologic aging or were elderly controls without neurodegenerative disorders59. We downloaded the corresponding clinical data (covariates) from the Accelerating Medicines Partnership -Alzheimer's Disease (AMP-AD) Knowledge Portal60. Specifically, we used the synapseClient R package v1.15-0 (hp://www.sagebase.org) to download temporal cortex (syn5223705) and cerebellum (syn3817650) clinical data. Dr. Nilufer Taner at the Mayo Clinic provided us with unprocessed RNA-seq data.
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Data analysis
Drosophila: After standard and small-RNA sequencing, CASAVA was used for demultiplexing and fastq files were generated for each sample. For data cleaning, SortMeRNA49 v2.1 was used to identify and exclude ribosomal RNA reads, and Trimmomatic50 v0.36 was used to remove Illumina adaptors. FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) v0.11.5 was used for a quality check before and after the above cleaning steps. The quality of bases in the cleaned reads was above 28 (Sanger/Illumina 1.9 encoding). Reads were aligned to the transposon reference FASTA files (FlyBase51 Release 6.12), and the quantity of each transposable element was calculated using Salmon52 v0.7.2. On average, 9 million reads were mapped per sample. DESeq253 v1.14.1 was used to identify sequences that were differentially expressed in tau transgenic Drosophila compared to controls. Ensembl BioMarts54 was used to assign genomic locations of differentially expressed transcripts (Supplementary Table 2 ). Pheatmap (https://CRAN.R-project.org/ package=pheatmap) v1.0.8 and Pigengene55 v1.3.4 R56 packages were used to generate heatmaps. Values in transposable element heatmaps are standardized Transcripts Per Million57 (TPM). For presentation clarity in Fig. 1 , we subtracted the TPM value of each transposable element from its average across all samples, and then divided the difference by the standard deviation of the TPM value of that particular transposable element. Unscaled heatmaps ( Supplementary Fig. 1 ) represent raw TPM. piRNA small RNA-seq analyses were similar to the above, with some exceptions. As some tRNAs are mis-annotated as piRNAs, piRNAs that were a subsequence of a tRNA (FlyBase51 Release 6.16) were removed from analysis. Reads were mapped to the remaining piRNA sequences (piRNABank58) as the reference. On average, 16 million reads were mapped per sample. piRNAs with low coverage were excluded as follows: If the sum of reads that mapped to a piRNA in all four tau transgenic Drosophila samples was less than three, we considered its expression "undetectable" in tau transgenic samples. Similarly, if the sum of reads that mapped to a piRNA in all four control normal samples was less than three, we considered its expression undetectable in controls. If a piRNA had undetectable expression values both tau transgenic and control samples, it was excluded from our analysis. Raw data for small RNA-seq are included in Supplementary Table 5 , and genomic locations of differentially expressed piRNAs are included in Supplementary Table 6 .
Human: We converted raw bam files to fastq files using the Picard SamToFastq v2.10.10 tool (http://broadinstitute.github.io/picard). We downloaded human transposable elements from the Genetic Information Research Institute (GIRI) RepBase64 database in fasta format (http://www.girinst.org/repbase/update/browse.php? type=All&format=FASTA&autonomous=on&nonautonomous=on&simple=on&division=Homo+sapiens&letter=A). The file contains 1073 unique sequences including the 549 ancestral repeats that are shared among all mammals. Using the same pipeline that we described for the analysis of Drosophila RNA-seq data, we cleaned the fastq files, aligned them to the human transposable element sequences, and performed differential expression analysis.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
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-Accession codes, unique identifiers, or web links for publicly available datasets -A list of figures that have associated raw data -A description of any restrictions on data availability Raw counts from RNA sequencing are provided as Supplementary Tables. Full access to bam files that include Drosophila transposable element and piRNA reads will be made publicly available upon publication. Custom codes that were created for cleaning and analyzing sequencing data will be made available upon publication.
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Data exclusions Exclusion criteria were pre-established prior to data analysis.
For Drosophila piRNA small RNA-seq analyses, as some tRNAs are mis-annotated as piRNAs, piRNAs that were a subsequence of a tRNA (FlyBase51 Release 6.16) were removed from analysis. Reads were mapped to the remaining piRNA sequences (piRNABank58) as the reference. piRNAs with low coverage were excluded as follows: If the sum of reads that mapped to a piRNA in all four tau transgenic Drosophila samples was less than three, we considered its expression "undetectable" in tau transgenic samples. Similarly, if the sum of reads that mapped to a piRNA in all four control normal samples was less than three, we considered its expression undetectable in controls. If a piRNA had undetectable expression values both tau transgenic and control samples, it was excluded from our analysis. For human RNA-seq data, 12 cortex (syn6126114) and 10 cerebellum (syn6126119) samples were excluded due to low quality by the Mayo Clinic61,62. In this study, we also excluded 9 cortex and 15 cerebellum samples that had an RNA Integrity Number (RIN)63 less than 7.
